ArticleFrontiers in immunology2025

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Qianyi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.